BRD2 and epilepsy: A consistent statistical difference was observed among epilepsy patients and controls with regards to FP FSH [10.48 ± 15.01 vs. 4.56 ± 3.29; p0.007], FP progesterone [7.53 ± 14.20 vs. 15.20 ± 32.18; p0.037], FP estradiol [135.33 ± 143.62 vs. 206.09 ± 77.02; p0.001], LP progesterone [6.92 ± 13.38 vs. 12.08 ± 12.46; p0.022], and testosterone [3.28 ± 9.99 vs. 0.31 ± 0.30; p0.037] (see Table 2).